Liberum Capital Reaffirms Buy Rating for Plant Health Care plc (LON:PHC)
Plant Health Care plc (LON:PHC)‘s stock had its “buy” rating reaffirmed by Liberum Capital in a note issued to investors on Monday. They currently have a GBX 45 ($0.58) price objective on the stock. Liberum Capital’s price target would indicate a potential upside of 80.00% from the company’s previous close.
Shares of Plant Health Care plc (LON PHC) traded down 6.132% during trading on Monday, reaching GBX 24.875. The company’s stock had a trading volume of 64,450 shares. Plant Health Care plc has a 52-week low of GBX 13.00 and a 52-week high of GBX 45.00. The firm’s 50-day moving average is GBX 28.07 and its 200 day moving average is GBX 22.07. The company’s market cap is GBX 36.77 million.
In related news, insider Richard Webb bought 80,825 shares of the stock in a transaction that occurred on Tuesday, May 23rd. The stock was acquired at an average cost of GBX 30 ($0.39) per share, with a total value of £24,247.50 ($31,408.68). Also, insider Christopher (Chris) Richards bought 20,000 shares of the stock in a transaction that occurred on Tuesday, June 13th. The shares were bought at an average cost of GBX 29 ($0.38) per share, with a total value of £5,800 ($7,512.95). Insiders have acquired 115,403 shares of company stock valued at $3,398,356 over the last 90 days.
Plant Health Care plc Company Profile
Plant Health Care plc provides agricultural biological products and technology solutions. The Company’s segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products.
Receive News & Ratings for Plant Health Care plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plant Health Care plc and related companies with MarketBeat.com's FREE daily email newsletter.